The inhibition of either NRG1 or PAK1 (BD+anti-NRG1+LT and BD+anti-PAK1+LT groups) decreased VEGFA in non-steatotic livers, while no changes were observed in the presence of steatosis when compared with the results obtained in the BD+LT group. This evidence concerns the gene VEGFA and Behcet disease.